CAMBRIDGE, Mass. , Oct. 07, 2020 (GLOBE NEWSWIRE) -- Today, Jennifer Doudna , Ph.D., one of Intellia Therapeutics , Inc.’s scientific co-founders, was awarded the 2020 Nobel Prize in Chemistry for the development of the CRISPR/Cas9 genome editing technology. Dr.